4 1 form4foscue_march2003.txt FORM 4 - STATEMENT OF CHANGES IN BENEFICIAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. 1. Name and Address of Reporting Person(s) Charles T. Foscue 336 Bollay Drive Santa Barbara, CA 93117 2. Issuer Name and Ticker or Trading Symbol Miravant Medical Technologies (MRVT) 3. I.R.S. Identification Number of Reporting Person, if an entity (Voluntary) 4. Statement for Month/Day/Year 02/22/02 5. If Amendment, Date of Original (Month/Day/Year) 6. Relationship of Reporting Person(s) to Issuer (Check all applicable) [X] Director [ ] 10% Owner [ ] Officer (give title below) [ ] Other (specify below) 7. Individual or Joint/Group Filing (Check Applicable Line) [X] Form filed by One Reporting Person [ ] Form filed by More than One Reporting Person
Table I Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned ------------------------------------------------------------------------------------------------------------------------------------ 1)Title of Security 2)Trans- 2A.Deemed 3.Trans- 4.Securities Acquired(A) 5)Amount of 6) 7)Nature of action execution action or Disposed of (D) Securities Indirect Date Date, if Code A Beneficially D Beneficial (Month/ any (Month/ or Owned at or Ownership Day/Year) Day/Year) Code V Amount D Price End of Month I ------------------------------------------------------------------------------------------------------------------------------------ Table II (PART 1) Derivative Securities Acquired, Disposed of, or Beneficially Owned (Columns 1 through 6) ------------------------------------------------------------------------------------------------------------------------------------ 1)Title of Derivative 2)Conversion 3)Trans- 3A)Deemed 4)Trans- 5)Number of Derivative 6)Date Exercisable and Security or Exercise action Execution action Securities Acquired (A) Expiration Date Price of Date Date, if Code or Disposed of (D) Derivative (Month/ any(Month/ Security (Day/Year) (Day/Year) Code V A D Exercisable Expiration ------------------------------------------------------------------------------------------------------------------------------------ Non-Qualified Stock Option $0.5100 11/26/02 (1) 11/26/02 (1) A 50,000 11/26/03 11/26/12 (right to buy) Non-Qualified Stock Option $0.5100 11/19/02 (2) 11/19/02 (2) A 7,500 11/19/02 11/19/12 (right to buy) Non-Qualified Stock Option $0.9100 02/22/02 (1) 02/22/02 (1) A 50,000 02/22/03 02/22/12 (right to buy) Table II (PART 2) Derivative Securities Acquired, Disposed of, or Beneficially Owned (Columns 1,3 and 7 through 11) ------------------------------------------------------------------------------------------------------------------------------------ 1)Title of Derivative 3)Trans- 3A)Deemed 7)Title and Amount 8)Price 9)Number of 10) 11)Nature of Security action Execution of Underlying of Deri- Derivative Indirect Date Date, if Securities vative Securities D Beneficial (Month/ any(Month/ Amount or Security Beneficially or Ownership Day/Year) (Day/Year) Number of Owned at I - Title Shares End of Month ------------------------------------------------------------------------------------------------------------------------------------ Non-Qualified Stock Option 11/26/02 11/26/02 Common Stock 50,000 $0.5100 50,000 D Direct (right to buy) (1) Non-Qualified Stock Option 11/19/02 11/19/02 Common Stock 7,500 $0.5100 7,500 D Direct (right to buy) (2) Non-Qualified Stock Option 02/22/02 02/22/02 Common Stock 50,000 $0.9100 50,000 D Direct (right to buy) (1) Explanation of Responses: (1) Stock options vest quarterly over two years commencing on the date of grant. (2) Automatic grant to outside director in consideration of service as board member.
SIGNATURE OF REPORTING PERSON /S/ Charles T. Foscue ------------------- Charles T. Foscue DATE March 04, 2003